Skip to content
healthcare.dev

UZEDY

NDC 51759-305, risperidone, injection, suspension, extended release, from Teva Pharmaceuticals USA, Inc..

Product NDC
51759-305
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213586
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51759-305 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISPERIDONE50 mg/.14mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
51759-305-10517590305101 SYRINGE, GLASS in 1 CARTON (51759-305-10) / .14 mL in 1 SYRINGE, GLASS
51759-305-11517590305111 SYRINGE, GLASS in 1 CARTON (51759-305-11) / .14 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/734eb776-4be0-4808-834b-0d8b0f9e021e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=51759-305
  • NADAC price for package 51759030510

    GET /v1/drugs/nadac/51759030510

Use it

Look up 51759-305 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51759-305 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51759-305. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.